Skye Bioscience Announces Participation in February Conferences
Provided By GlobeNewswire
Last update: Feb 4, 2025
SAN DIEGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will participate in the following investor conferences:
Read more at globenewswire.com
